Endothelin is a potent vasoconstrictive peptide first isolated from the supernatant of cultured porcine aortic endothelial cells. The purpose of this study was to determine the source of endothelin-1 (ET-1) production in rat uterus during pregnancy and to claflfy its role in normal pregnancy. ET-1, as recognized by immunohistochemistry, was weakly expressed only in endometrial glandular cells in nonpregnant rats but was intensely expressed in both glandular and myometrial cells in the early postpartum period. In situ hybridization confirmed the localization of prepro-ET4 mRNA in the cytoplasm of endometrial glandular and myometrial cells but not in stromal cells or in smooth muscle cells of blood vessels. Northern blot analysis detected prepro-ET-1 mRNA in
Introduction
Recently, a novel potent vasoconstrictive peptide termed endothelin (ET), consisting of 21 amino acid residues, has been isolated from the supernatant of cultured porcine aortic endothelial cells (Yanagisawa et al., 1988) . Later, three isopeptides of ET, ET-1, ET-2, and ET-3, were identified by screening of a human genomic DNA library (Inoue et al., 1989) . It has been reported that mRNA for ET-1 is widely expressed in vascular endothelial cells as well as in other cell types (Sakurai et al., 1991) . Subsequently, two distinct subtypes of ET receptor have been identified that are widely distributed in many cell types (Arai et al., 1990; Sakurai et al., 1990) . ET-1 has been shown to have various biological activities, including vasoconstriction and mitogenesis (Simonson et al., 1989; Takuwa et al., 1989; Komuro et al., 1988) . A high level of ET-1 immunoreactivity has been found in human amniotic fluid (Usuki et al., 1990) , and immunoreaction for ET-1 has been demonstrated in endometrial glandular cells (Cameron et al., 1992) and trophoblastic cells (Kaneko et al., 1992) in addition to the endothelial cells. However, the cellular distribution and possible sites of production of ET-1 in the uterus have not yet been fully established. Moreover, little is known about the role of ET-1 in placenta, decidua, and ' Correspondence to: Takeshi Kajihara, MD. Dept. of Obstetrics and Gynecology, Saitama Medical School, 38 Morohongo, Moroyama, Irumagun, Saitama, Japan. myometrial tissue from pregnant but not nonpregnant rats. In particular, the expression of prepro-ET-1 mRNA was strongest in the early postpvtum period compared with the various stages of pregnancy. These results indicate that, in addition to endothelial cells and endometrial glandular cclls, myometrial cells also produce ET-1 and its production significantly increases in the early postpartum period. Therefore, ET-1 may play a pivotal role in controlling bleeding from the placental bed through myometrial contraction. (1 19%) KEY WORDS: Endothelin-1; Immunohistochemistry; In situ hybridization; Northern blot analysis; Rat; Uterus during pregnancy. uterine muscle during normal pregnancy. The purpose of the present study was to determine the actual sources of ET-1 production in rat uterus at different gestational ages and to clarify its role in normal pregnancy.
Materials and Methods
Animals and Tissues. Virgin Wistar-Imamichi rats, 10 weeks old, were used. The rats had a normal sexual cycle for at least two cycles, as determined by vaginal smears, and were mated at pre-estrus. The day on which a morning vaginal smear was found to contain spermatozoa was assigned as Day 0 of pregnancy. Under ether anesthesia, the uterine horns were excised from nonpregnant rats and from pregnant rats on Day 9. 14, or 20, and on early postpartum Day 1 and Day 5 . The rats were suckling on Day 1 through Day 5 . The uterine tissues were resected and processed for light microscopic immunohistochemistry and in situ hybridization (ISH). Myometrial tissues from nonpregnant rats, as well as from pregnant rats on Days 14, 20, and early postpartum were used for Northern blot analysis.
Light Microscopic Immunohistochemistry. The tissues were fmed in neutralized 10% formalin solution and embedded in paraffin by standard methods. Tissue sections 2.5 pm thick were stained by an avidin-biotin-peroxidase method. After deparaffinization, the sections were sequentially treated with methanol containing 0.3% hydrogen peroxide for 30 min to block endogenous peroxidase activity and 10% normal goat serum for 10 min at room temperature (RT) to block nonspecific immunoreactive sites. The sections were then incubated with a 1:10 dilution ( 5 pglml) of affinitypurified rabbit antiserum to ET-1 (IBL; Fujioka, Japan) at 4'C for 48 hr.
The antibody had been raised against the synthetic ET-1 peptide (Nakamura et al., 1993) and preabsorbed with ET-3 AvidGel F (IBL). Enzyme immunoassay had revealed that this antibody crossreacted at 100% with big ET-1. but at I%, 0.2%. 0.4%, and 0.4%, respectively, with ET-2, big ET-2 (Ohkubo et al., 1989), ET-3. and big ET-3 (Bloch et al., 1989) . Afterwashes in 0.01 M PBS. pH 7.4, the sections were incubated with biotinylated goat anti-rabbit immunoglobulins, washed in PBS, and incubated with streptavidin-biotin-peroxidase complex using a Histofine SAB-PO(R) kit (Nichirei; Tokyo, Japan). The sections were thoroughly washed with PBS and the peroxidase reaction was developed with 0.02% 3,3'-diaminobenzidine tetrahydrochloride (DAB) and 0.005 % hydrogen peroxide in 0.05 M Tris-HCI buffer, pH 7.6, for 5 min. Nuclear counterstaining was done with Mayer's hematoxylin. Negative control sections were incubated with the primary antibody preabsorbed with excessive synthetic ET-1 (a mixture of one part of 5 pg/ml primary antibody and one part of 15 pg/ml synthetic ET-1 after 2-hr incubation at RT).
In Situ Hybridization. The rat prepro-ET-1 cDNA probe (0.6 KB) was labeled with digoxigenin-dUTP by the random priming method using a DIG DNA labeling and detection kit (Boehringer Mannheim; Mannheim, Germany). cDNA cloning and sequence analysis of this probe have been reported previously (Sakurai et al., 1991) . Frozen tissue sections 5 pm thick were fixed in periodate-lysine-paraformaldehyde (McLean and Nakane. 1974) solution. The sections were incubated with proteinase K (2 pglml) for 15 min at 37°C and postfixed in 4% paraformaldehyde-PBS for 5 min at RT. Then the sections were soaked twice in glycine-PBS (2 mglml) for 15 min and kept in 50% formamide-2 x SSC. After 30-min prehybridization at 42°C in hybridization buffer containing 4 x SSC, 50% formamide (vlv), 1 x Denhardt's, 0.5 mglml salmon sperm, 0.25 mg/ml yeast RNA, and 10% dextran sulfate (vlv), the sections were incubated with 50 nglml of the labeled prepro-ET-1 cDNA probe or, for the control, the labeled sense probe in hybridization buffer for 12 hr at 42°C. The sections were washed twice with 0.2 x SSC and 0.1% Tween 20 for 15 minutes at 52"C, washed with Buffer 1 (100 mM Tris-HCI, 150 mM NaCI, pH 7.6) for 3 min, and incubated with Buffer 2 (0.3% normal sheep serum, 100 mM Tris-HCI, 150 mM NaCI, pH 7.5) for 30 min at RT. After washing with Buffer 1, the sections were incubated with a 1:lOOO dilution in Buffer 1 ofpolyclonal sheep anti-digoxigenin Fab fragments conjugated with alkaline phosphatase for 1 hr at RT, washed three times with Buffer 1, and soaked in Buffer 3 (100 mM Tris-HCI, 100 mM NaCI, 50 mM MgC12, pH 9.5) for 5 min. Then the sections were incubated with Buffer 3 containing NBT (nitroblue tetrazollium) and BCIP (~-bromo-4-chloro-3-indolylphosphate) in the dark. No counterstaining was done.
Northern Blot Analysis. Total RNA was extracted from the myometrium by the acid guanidium-phenol-chloroform method (Chomczynski and Sacchi, 1987) and enriched for mRNA using oligo(dT)-latex. Poly(A)'-enriched RNA samples (10 pg) were size-fractionated by electrophoresis on 1% formaldehyde-agarose gels and transferred to a nylon membrane. The rat prepro-ET-1 cDNA probe (0.6 KB) was labeled with (r~-~~P]-deoxy-CTP using a Ready-To-Go DNA labeling kit (-dCTP) (Pharmacia Biotech; Uppsala, Sweden). The membrane was prehybridized for 16 hr at 42°C in hybridization buffer containing 5 x SSC, 4 x Denhardt's, 50% formamide (v/v), 50 mM sodium phosphate, and 40 pglml salmon sperm DNA. Hybridization was carried out for 16 hr at 42°C in hybridization buffer added to the labeled probe. After hybridization, the blots were washed three times with 2 x SSC and 0.1 x SDS for 10 min at RT and three times in 0.1 x SSC and 0.1 x SDS for 30 min at 50°C. The membrane was then exposed to X-ray film for 24 hr at -80°C. Thereafter, the blots were probed with cDNA for glucose-3-phosphate dehydrogenase (G3PDH) which was radiolabeled with [a-32P]-deoxy-CTP using the Ready-To-Go DNA labeling kit (-dCTP).
Results

Light Microscopic Immunohistochemistry
In nonpregnant rats, traces of the DAB reaction products of ET-1 were found in the glandular cells but not in the endometrial stromal cells and the myometrial cells ( Figure 1A) . In pregnant rats, ET-1 was expressed in the cytoplasm of both endometrial glandular and myometrial cells. Especially during the early postpartum period, ET-1 expression was most intense in the glandular and myometrial cells ( Figure 1B ) and the endothelial cells of uteroplacental vessels compared with other gestational ages. Positive reaction was also noted in the smooth muscle cells of blood vessel walls. In the labyrinth zone of placenta, ET-1 expression was observed in both endothelial and syncytial cells on Day 20 of pregnancy. In negative control sections using primary antibody preabsorbed with synthetic ET-1, no reactivity for ET-1 was detected ( Figure IC) .
In Situ Hybridization
At the early postpartum period, prepro-ET-1 mRNA was located in the cytoplasm of endometrial glandular cells and myometrial cells of uterine horns (Figure 2A, arrows) . However, prepro-ET-1 mRNA was not found in the endometrial stromal cells, although smooth muscle cell of blood vessels showed a positive reaction. In the labyrinth zone of placenta, prepro-ET-1 mRNA was also found in the cytoplasm of endothelial cells and syncytial cells on Day 20 of pregnancy. No signal was detected in the control tissue sections ( Figure 2B ).
Northern Blot Analysis
Prepro-ET-1 mRNA was detected as a hybridization band corresponding to 2.3 KB in all myometrial tissues except those of nonpregnant rats. In particular, the expression of prepro-ET-1 mRNA in the early postpartum period was strongest compared with the various stages of pregnancy (Figure 3 ).
Discussion
In the present study, ET-1 was expressed in the endometrial glandular cells and myometrial cells in the rat uterine horns. Especially in the early postpartum period, it was strongly expressed in the glandular cells, myometrial cells, and endothelial cells of uteroplacental vessels. The immunolocalization of ET-1 in the endometrial glandular cells has been reported (Cameron et al., 1992) . However, the presence of ET-1 in myometrial cells was not known. Our ISH observation of prepro-ET-1 mRNA localized in the myometrial cells, in addition to the endometrial glandular cells, substantiates that in rat uterine horns both endometrial glandular cells and myometrial cells produce ET-1.
In the labyrinth zone of placenta, ET-1 immunolocalization was observed in the cytoplasm of syncytial trophoblasts and endothelial cells, and ISH confirmed the presence of prepro-ET-1 mRNA in these cells. The immunohistochemical localization of ET-1 in syncytial trophoblasts has been also reported previously (Kaneko et al.. 1992). Whcthcr ET-1 was produced by thc samc cells or was produced by othcr cclls and transported to the syncytial trophoblasts was not evident. Thcreforc. in thc prcscnt study. the synthcsis of ET-1 in syncytial trophoblasts was cstablishcd.
Thc rolc of ET4 in the utcms of pregnant and postpartum subjccrs has not yet bcen understood. It is wcll known that ET-I induces contraction of human (Word ct al.. 1990) and rat (Okawa ct al., 1991) myometrium through its spccific rcccptors. In this study rhc production of ET-1 by myometrial cells was asccrtaincd, and by Northern blot hybridization strong cxprcssion of prepro-ET-1 mRNA in myometrium was found in thc early postpartum. Thcse findings suggcst that ET-I produced by myomctrial cclls acts as an autocrinc substance through its spccific rcceptors and causcs strong contraction of myometrium in the postpartum period. At prcscnt, thc cxprcssion of prcpro-ET4 mRNA prcviouslv found in amnionic mcmbranc and the prcscncc of ET-I immunorcactiviry found in amniotic cell culture mcdia (Cascy et al.. 1991) have Icd to thc assumption that thc amniotic membrane is onc tissue sourcc of ET-I during prcgnancy. Howcvcr. in our study thc fact that m y omctrial cells arc also a source of ET-I inducing myometrial contraction was cstablishcd. Because ET-I induces potent myometrial contraction. its production by myomctrial cclls sccms pertinent.
Rcccntly. it was rcportcd that ET-1 binding sitcs wcrc prcscnt on human cndomctrial glandular cclls (Davenport et al., 1991) and that ET-I stimulated prostaglandin F2a rclcase from human cndomctrium (Camcron et al.. 1991) . Furthcrmorc. our prcscnt immunohistochcmistry and ISH studies confirmed that thc cndomctrial glandular cclls produce ET-I. Thcrdore, it is possiblc that ET-I produced by cndomctrial glandular cclls reaches thc myometrium and induces uterine horn contractions dircctly or indirectly through thc release of prostaglandin F2a from cndomctrium. Howcvcr. there are other possible roles for ET-1 in endometrial glandu-lar cclls. It was gcncrally secn that ET-I stimulatcd thc prolifcration of many cell typcs. including vascular smooth muscle cclls (Komuro ct al., 1988) . fibroblasts (Takuwa ct al.. 1989) . and kidney mcsangial cells (Simonson ct al., 1989) . It is possiblc that ET-I produced in cndomctrial glandular cells has a mirogcnic function for somc ccll typcs in cndomctrial tissue.
Our study demonstrated that in thc labyrinth zonc of placenta ET-1 was produced by the endorhclial cclls and syncytial trophoblasts. It has been previously reported that thc ET-1 receptor is exprcsscd on the mcmbrancs from human placenta (Nakajo ct al.. 1989) . Thew results suggcst that ET4 may play a rolc in fctoplaccnral circulation to maintain pregnancy. Furrhcr studies arc necdcd to clarify this hypothesis.
In conclusion. rhc prcscnt study dcmonstratcd that in addition to thc cndomerrial glandular cells, the myometrial cclls also produce ET-I and in particular. rhc production of ET-I in mvomctrium incrcascs during thc carly postpartum. Our prcscnt data suggcst that afrcr dclivcrv thc production of prostaglandin and ET-I rapidly ccascs in the placental bcd. because rhc decidua. which mainly produces prostaglandins and ET-I. is almost removed with rhc placenta. leaving the vcssels in the placcntal bed cxposcd to the utcrinc cavity. ET-1 produced by cndomctrial glandular cclls and cspccially by myometrial cclls. in association with oxytocin and prostaglandins. may thercforc play a pivotal role in controlling blccding from thcsc vcssels through myometrial contraction. In thc labyrinth zonc of placcnta in normal pregnancy. ET-I is synthcsized in rhc endothclial cclls and syncytial trophoblasts which may play an important rolc in fetoplaccntal circulatory function.
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